Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified | Sell | $81.6K | SEC | ||
Echo Therapeutics, Inc.Listing unverified | Buy | $23.4K | conv 31Cluster | SEC | |
Echo Therapeutics, Inc.Listing unverified | Buy | $121.2K | conv 28Cluster | SEC | |
Echo Therapeutics, Inc.Listing unverified | BuyD (derivative) | $3.8M | First in 12mo | SEC | |
Echo Therapeutics, Inc.Listing unverified | Buy | $153.1K | conv 40First in 12mo | SEC | |
Echo Therapeutics, Inc.Listing unverified | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | First in 12mo | SEC | |
Echo Therapeutics, Inc.Listing unverified | Buy | $38.3K | conv 34First in 12mo | SEC | |
Echo Therapeutics, Inc.Listing unverified | BuyD (derivative) | $961.7K | First in 12mo | SEC | |
Echo Therapeutics, Inc.Listing unverified | BuyD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | First in 12mo | SEC | |
NAVIDEA BIOPHARMACEUTICALS, INC.Listing unverified | Other | $7.7M | SEC |